GILD vs IPAR · P/E 18, rev $7.80B vs P/E 17, rev $685.9M
Gilead Sciences Inc (GILD) versus Inter Parfums Inc (IPAR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported IPAR revenue for 2026-06-30 was $685.9M. Net income was $73.9M. Revenue was up 98.9% from 2026-03-31 to 2026-06-30. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Not investment advice. Open the GILD and IPAR stock pages for the full models.
Not investment advice.